CAS: 2083618-79-3
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | N-(2,5-Dimethyl-4-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamido)phenyl)-8-oxo-5,6,7,8-tetrahydro-1H-cyclopenta[D][1,2,4]triazolo[1,5 -a]pyrimidine-2-carboxamide REF: 3D-IID61879CAS: 2083618-79-3 | Min. 95% | A consultar | Qua 13 Nov 24 |
 | PDZ1i REF: TM-T63797CAS: 2083618-79-3 | - - - | 1.386,00 €~2.279,00 € | Qua 20 Nov 24 |
N-(2,5-Dimethyl-4-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamido)phenyl)-8-oxo-5,6,7,8-tetrahydro-1H-cyclopenta[D][1,2,4]triazolo[1,5 -a]pyrimidine-2-carboxamide
CAS:2083618-79-3
N-(2,5-Dimethyl-4-(3-(5-phenyl-1,3,4-oxadiazol-2-yl)propanamido)phenyl)-8-oxo-5,6,7,8-tetrahydro-1H-[1] -cyclopenta[D][1,2,4]triazolo[1,5]pyrimidine-2 -carboxamide is a peptidomimetic inhibitor of the protein kinase PIM. It has been …
Fórmula:
C28H26N8O4
Pureza:
Min. 95%
Peso molecular:
538.6 g/mol
Ref: 3D-IID61879
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Quarta-feira 13 de Novembro de 2024
PDZ1i
CAS:2083618-79-3
PDZ1i: potent MDA-9/Syntenin inhibitor; crosses blood-brain barrier; targets GBM, FAK, EGFRvIII; lowers MMP secretion.
Fórmula:
C28H26N8O4
Cor e Forma:
Solid
Peso molecular:
538.56
Ref: TM-T63797
| 25mg | 1.386,00 € | ||
| 50mg | 1.805,00 € | ||
| 100mg | 2.279,00 € |
Entrega estimada em Estados Unidos, Quarta-feira 20 de Novembro de 2024
